Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study
Elif Car, Liese Barbier, Ingrid Schwarzenberger, Isabelle Huys, Steven Simoens, Arnold G. Vulto
Springer Nature ·
2025-10-21
· DOI 10.1007/s40259-025-00746-w
The publisher did not provide an abstract — full text is available via the link below.
Elif Car, Liese Barbier, Ingrid Schwarzenberger, Isabelle Huys, Steven Simoens, Arnold G. Vulto. Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study. // BioDrugs. – 2025. – DOI: 10.1007/s40259-025-00746-w. – URL: https://doi.org/10.1007/s40259-025-00746-w
Elif Car, Liese Barbier, Ingrid Schwarzenberger, Isabelle Huys, Steven Simoens, & Arnold G. Vulto (2025). Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study. BioDrugs. https://doi.org/10.1007/s40259-025-00746-w
Elif Car, et al. “Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study.” BioDrugs, 2025. doi:10.1007/s40259-025-00746-w.
@article{Car2025,
title = {Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study},
author = {Car, Elif and Barbier, Liese and Schwarzenberger, Ingrid and Huys, Isabelle and Simoens, Steven and Vulto, Arnold G.},
journal = {BioDrugs},
year = {2025},
doi = {10.1007/s40259-025-00746-w},
url = {https://doi.org/10.1007/s40259-025-00746-w}
}